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Prevalence, clinical profile, cause of hospitaliza-
tion and outcomes in patients with left bundle
branch block in the state of Qatar
Fahad Alkindi, Abulrahman Arabi, Ashfaq Patel,
Rajvir Singh, Jassim Alswaidi, Hajar A. Hajar
Albinali
Objectives: We studied the prevalence, clinical char-
acteristics, management and outcome among patients
with LBBB hospitalized in the cardiology department.
Methods: Retrospective analysis of the 22-year regis-
try data (Jan 1991 to Jun 2012) of cardiac patients hospital-
ized at Hamad General Hospital and Qatar Heart
Hospital, Doha, Qatar.
Results: Of the 41438 patients admitted under cardi-
ology department, 582 patients had LBBB (1.4%). Com-
pared to patients without LBBB, LBBB patients were
older (63 ± 12 vs. 54 ± 12 ears, P = 0.001), more likely to
be female (33 vs.23%, P = 0.001) and to be middle east-
ern(76.5 vs. 54%). LBBB patients have more hypertension
(56 vs. 40%, P = 0.001), Diabetes (52% vs. 39%, P = 0.004)
and chronic renal failure (11% vs.4%, P = 0.001),but less
likely to be current smoker (16% vs. 23%, P = 0.001).
CHF was the most common cause of admission in LBBB
(40% vs. 17% in no LBBB patients, P = 0.001), followed
by unstable angina (35 vs. 40%, P = 0.03) and myocardial
infarction (9.3 vs. 23%). In hospital mortality was signifi-
cantly higher in LBBB patients (8% vs. 4.7%, P = 0.001).
Conclusion: Patients with LBBB are more likely to
admitted with CHF, and less likely to be admitted with
acute coronary syndrome as compared to patients with-
out LBBB. Moreover LBBB is associated with a 2-folds
increase in mortality as compared to those without
LBBB.
http://dx.doi:10.1016/j.jsha.2013.03.068
Long term follow up of permanent pacing in
children
Fahad A. Al-Muqbil, Majid Al Fayyadh, Nuha
Al-Hefdhi, Abdulah Al-Wadai, Waleed Al-Manea,
Zuhair Al-Halees
Objective: To evaluate the experience and the long-
term results of pacemaker (PM) therapy in children.
Methods: We performed a retrospective analysis of
all patients (pts) who underwent PM implantation at
King Faisal Heart Institute. Data obtained include: demo-
graphics, diagnosis, indication for pacing, and follow up
evaluation.
Results: Between 1985 and 2012, 516 pts had PMs
implanted; mean age is 2.4 years (2days–18 years). The
most frequent indication are: surgical AV block 392 pts
(76%), congenital AV block 73 pts (14%), sinus node dys-
function 38 pts (7%). Surgical AV block was encountered
after relieve of left ventricular outflow tract obstruction,
ventricular septal defect (VSD) repair, and repair of com-
plex lesion associated with ventricular inversion. Con-
genital AV block was isolated in 58 pts; the remaining
had associated congenital heart defects (ventricular
inversion 10, VSD 2, coarctation 2, truncus arteriosus 1).
The initial PM system was epicardial in 412 pts (80%).
After a mean follow up of 4.2 years (1 month–25 years),
105 pts had 159 revision procedures (lead malfunction
73, battery depletion 77, PM infection 9). Lead malfunc-
tion was more encountered with epicardial leads. There
was no mortality directly related to the PM implantation
procedure or function however there were 21 pts lost
during the follow up and 14 pts (3%) had nonpacemaker
related death.
Conclusion: Pacemakers are safe and effective ther-
apy in children. Epicardial lead malfunction is a frequent
reason for pacemaker revision.
http://dx.doi:10.1016/j.jsha.2013.03.069
Transcatheter aortic valve implantation: Single
center experience with mid-term follow-up
Feras Khaliel, Zohair Alhalees, Salman Alarfaj,
Hani Alsergani, Maie Shahed, Jehad Alburaiki
Background: Transcatheter aortic-valve implanta-
tion (TAVI) is an emerging intervention for the treatment
of high-risk patients with severe aortic stenosis and coex-
isting illnesses.
Methods: Between August 2009 and May 2012, we
have conducted a retrospective study underwent a bal-
loon expandable transcatheter xenograft (Edwards SAP-
IEN) and evaluated the intermediate-term all cause
mortality. Average STS and EuroSCORE II predicted risk
for mortality was 18.4 ± 8.9% and 7.6 ± 5.5%, respectively.
The end points included feasibility, safety, efficacy, and
durability.
Results: A total of 27 consecutive patients underwent
TAVI. Nine (33.3%) patients among them had it through
the trans-apical approach. The mean age was 76 ± 8
years; 41% of the patients were females. There was
100% successful implantation. Hospital and one-year
mortality were 2 (7.4%) and 4 (14.8%), respectively. At 1
year, the incidence of stroke was 1 (3.7%), infection 6
(22%), AV block 2 (7.4%), severe bleeding 2 (7.4%), vascu-
lar complication (14.8%), and the incidence of peripros-
thetic aortic regurgitation (<2) was 5 (18.5%). No patient
been converted to open surgery. There was a significant
improvement of patient left ventricular function post
TAVI (p = 0.001), and of aortic valve area (AVA) with
mean 0.4 ± 01cm2 ranging from 0.2 to 0.9 cm2 pre-and
1 ± 0.3 cm2 ranging from 1 to1.9 cm2 post-TAVI
(p = 0.0001). The aortic pressure gradients have improved
significantly from 45 ± 11 mm Hg pre-to 8.5± 5.5 mm Hg
post-implantation (p = 0.0001). For all patients the aver-
age length of follow-up by echocardiography was 346
days and was 100% completed.
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